Biotricity Stock Net Income
Biotricity fundamentals help investors to digest information that contributes to Biotricity's financial success or failures. It also enables traders to predict the movement of Biotricity OTC Stock. The fundamental analysis module provides a way to measure Biotricity's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biotricity otc stock.
Biotricity |
Biotricity OTC Stock Net Income Analysis
Biotricity's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Biotricity Net Income | (14.09 M) |
Most of Biotricity's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biotricity is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Biotricity reported net income of (14.09 Million). This is 104.13% lower than that of the Health Care Equipment & Supplies sector and 105.92% lower than that of the Health Care industry. The net income for all United States stocks is 102.47% higher than that of the company.
Biotricity Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biotricity's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Biotricity could also be used in its relative valuation, which is a method of valuing Biotricity by comparing valuation metrics of similar companies.Biotricity is currently under evaluation in net income category among its peers.
Biotricity Fundamentals
| Return On Equity | -41.01 | ||||
| Return On Asset | -0.89 | ||||
| Profit Margin | (1.17) % | ||||
| Operating Margin | (0.96) % | ||||
| Current Valuation | 38.87 M | ||||
| Shares Outstanding | 21.48 M | ||||
| Shares Owned By Insiders | 48.61 % | ||||
| Shares Owned By Institutions | 1.62 % | ||||
| Number Of Shares Shorted | 459.95 K | ||||
| Price To Earning | (6.70) X | ||||
| Price To Book | 33.02 X | ||||
| Price To Sales | 0.83 X | ||||
| Revenue | 12.06 M | ||||
| Gross Profit | 4.57 M | ||||
| EBITDA | (8.82 M) | ||||
| Net Income | (14.09 M) | ||||
| Cash And Equivalents | 2.89 M | ||||
| Cash Per Share | 0.05 X | ||||
| Total Debt | 23.88 M | ||||
| Debt To Equity | 6.45 % | ||||
| Current Ratio | 1.54 X | ||||
| Book Value Per Share | (3.31) X | ||||
| Cash Flow From Operations | (6.69 M) | ||||
| Short Ratio | 5.50 X | ||||
| Earnings Per Share | (1.66) X | ||||
| Target Price | 4.0 | ||||
| Number Of Employees | 55 | ||||
| Beta | 1.4 | ||||
| Market Capitalization | 10.02 M | ||||
| Total Asset | 5.94 M | ||||
| Retained Earnings | (127.5 M) | ||||
| Working Capital | (18.23 M) | ||||
| Current Asset | 11 K | ||||
| Current Liabilities | 303 K | ||||
| Net Asset | 5.94 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Biotricity information on this page should be used as a complementary analysis to other Biotricity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in Biotricity OTC Stock
If you are still planning to invest in Biotricity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biotricity's history and understand the potential risks before investing.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |